Cover Image

Study on clinical features and factors related to long‐term outcomes of antibody‐negative autoimmune encephalitis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Binhong Han, Yuwei Dai, Jian Peng, Tianxiang Yuan, Qing Yin, Li Yang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Annals of Clinical and Translational Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clonal hematopoiesis in LGI1‐antibody encephalitis
by: Soo Jean Shin, et al.
Published: (2024)

Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy
by: Wenzheng Xiong, et al.
Published: (2024)

Quantitative brain 18F‐FDG PET/CT analysis in seronegative autoimmune encephalitis
by: Samantha N. Roman, et al.
Published: (2024)

Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis
by: Sophie N. M. Binks, et al.
Published: (2024)

Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria
by: Michael Gilligan, et al.
Published: (2024)

Psychiatric manifestations of encephalitis
by: Paris Bean, et al.
Published: (2025)

Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study
by: Tobias Moser, et al.
Published: (2024)

The clinical relevance of MOG antibody testing in cerebrospinal fluid
by: Molly Reynolds, et al.
Published: (2024)

Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)
by: Mark J Kelly, et al.
Published: (2025)

Gait speed after mild stroke/transient ischemic attack was associated with long‐term adverse outcomes: A cohort study
by: Ning Li, et al.
Published: (2024)

A case of immunotherapy‐responsive autoimmune hemichorea
by: Rachel E. Rodin, et al.
Published: (2024)

POLR3A‐related disorders: From spastic ataxia to generalised dystonia and long‐term efficacy of deep brain stimulation
by: Wai Yan Yau, et al.
Published: (2024)

Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay
by: Yana Said, et al.
Published: (2025)

Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis
by: Jack A. Reeves, et al.
Published: (2024)

CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity
by: Yahel Segal, et al.
Published: (2025)

Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study
by: Fei Jiang, et al.
Published: (2024)

Peripheral nervous system manifestations of MOG antibody associated disease
by: Pranjal Gupta, et al.
Published: (2024)

Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody‐associated disease
by: Ruth Schneider, et al.
Published: (2024)

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity
by: Jeffrey L. Bennett, et al.
Published: (2024)

Correction to α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
Published: (2025)

Decoding the biology and clinical implication of neutrophils in intracranial aneurysm
by: Hang Ji, et al.
Published: (2024)

Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington's disease
by: Hiba Bilal, et al.
Published: (2024)

Structural and functional imaging features of cognitive phenotypes in pediatric multiple sclerosis
by: Damiano Mistri, et al.
Published: (2024)

Predicting outcome in disorders of consciousness: A mega‐analysis
by: Yuri G. Pavlov, et al.
Published: (2024)

Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL
by: Nannan Han, et al.
Published: (2024)

Intermittent hypoxia training improves cerebral blood flow without cognitive impairment
by: Qihan Zhang, et al.
Published: (2024)

Matched oligoclonal bands: Diagnostic utility and clinical characteristics
by: Yoji Hoshina, et al.
Published: (2024)

Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
by: Kian Jalaleddini, et al.
Published: (2024)

SCAR32 : Functional characterization and expansion of the clinical‐genetic spectrum
by: Valentina Naef, et al.
Published: (2024)

Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcome
by: Francesca Nardecchia, et al.
Published: (2024)

Objective and subjective cognitive outcomes one year after COVID‐19
by: Laura Zamarian, et al.
Published: (2024)

Overlap of spike and ripple propagation onset predicts surgical outcome in epilepsy
by: Saeed Jahromi, et al.
Published: (2024)

Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke
by: Liuping Cui, et al.
Published: (2024)

Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion
by: Omid Shirvani, et al.
Published: (2024)

Locked‐in syndrome after central pontine myelinolysis, an outstanding outcome of two patients
by: Maïlys Chabert, et al.
Published: (2024)

Cerebral autoregulation in patients with acute lacunar infarction: a reliable predictor of outcome
by: Xiang‐Kun Si, et al.
Published: (2025)

Adaptive behavior assessed by Vineland‐3 as comprehensive outcome measure in vanishing white matter
by: Daphne H. Schoenmakers, et al.
Published: (2024)

Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study
by: Lin Wan, et al.
Published: (2024)

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold
by: Gabriel Bsteh, et al.
Published: (2024)

Infantile Krabbe disease (0–12 months), progression, and recommended endpoints for clinical trials
by: Melissa R. Greco, et al.
Published: (2024)